About LISIX
Lazard International Strategic Equity Portfolio – Institutional Shares is an actively managed mutual fund focused on international equity investments. Its primary goal is to achieve long-term capital appreciation by investing predominantly in common stocks of non-U.S. companies, spanning both developed and emerging markets but excluding the United States. The portfolio is unconstrained by a benchmark, providing management with flexibility to seek opportunities across the global equity landscape.
The fund emphasizes stocks that the management team considers undervalued, even if these companies may not realize their perceived value in the short term. Its investment style is characterized as large growth within the foreign large blend category, and it typically holds a diversified set of equity positions, with the top ten holdings representing about 30% of total assets. Key sectors impacted include healthcare, technology, industrials, and financial services, as evidenced by top holdings like Novo Nordisk, RELX, ASML, and Icon PLC.
With total assets of approximately $3.8 billion and a turnover rate of 43%, the fund is designed for institutional investors, requiring a significant minimum initial investment. The portfolio plays a strategic role for investors seeking broad international diversification and exposure to growth opportunities outside the U.S..
Fund Family Lazard
Category Foreign Large Blend
Performance Rating Below Average
Risk Rating Average
Stock Exchange NASDAQ
Ticker Symbol LISIX
Share Class Institutional Shares
Index FTSE World TR USD
LISIX had a total return of 16.51% in the past year, including dividends. Since the fund's
inception, the average annual return has been 6.65%.
